Literature DB >> 30078501

Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.

Xi Zhang1, Li Zhang1, Shuai Xue1, Peisong Wang1, Guang Chen2.   

Abstract

BACKGROUND: Solitary papillary thyroid microcarcinoma (PTMC) without gross extrathyroidal extension (ETE) were the main candidates for active surveillance (AS). Predictive factors of lateral lymph node metastasis (LLNM) in solitary PTMC without gross ETE were essential but still unknown.
METHODS: Altogether, 171 patients of solitary PTMC without gross ETE were enrolled in our study and divided into two groups. Group A: 123 patients without lateral lymph node dissection (LLND) were considered to be LLNM negative because there was no lateral recurrence by at least 8-year follow up for all patients. Group B: 48 patients with LLND were considered to be LLNM positive which confirmed by postoperative pathology.
RESULTS: Multivariate logistic regression showed male gender, upper location of tumor and diameter of tumor ≥7 mm to be predictive factors (odds ratio = 4.237 [confidence interval (CI) 1.365-13.149, p = 0.012; odds ratio = 2.933 [CI 1.117-7.700, p = 0.029; odds ratio = 4.557 [CI 1383-15.016, p = 0.013) for LLNM in solitary PTMC patients without gross ETE. Multiple level metastasis happened in 29 (60.42%) cases while single level metastasis in 19 (39.58%). Within the lateral cervical lymph node chain, level Ⅲ nodes were consistently the most frequently involved (38/48, 79%), following by level Ⅳ (27/48, 56%), level Ⅱ (25/48, 52%) and level V (5/48, 10%). Most interesting, there are 12 (12/48, 25%) skip metastatic (positive in lateral neck and negative in central neck) patients among LLNM positive group.
CONCLUSIONS: Male gender, upper location of tumor and diameter of tumor ≥0.7 cm to be predictive factors of LLNM in solitary PTMC without gross ETE.
Copyright © 2018. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Extrathyroidal extension; Lateral lymph node metastasis; Papillary thyroid microcarcinoma; Predictive factor

Mesh:

Year:  2018        PMID: 30078501     DOI: 10.1016/j.asjsur.2018.07.003

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  5 in total

1.  Invasiveness and Metastatic Aggressiveness in Small Differentiated Thyroid Cancers: Demography of Small Papillary Thyroid Carcinomas in the Swedish Population.

Authors:  Haytham Bayadsi; Martin Bergman; Malin Sund; Joakim Hennings
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

2.  Routine Lateral Level V Dissection May Not Be Necessary for Papillary Thyroid Microcarcinoma With Lateral Lymph Node Metastasis: A Retrospective Study of 252 Cases.

Authors:  Shuai Xue; Peisong Wang; Qiang Zhang; Yue Yin; Liang Guo; Ming Wang; Meishan Jin; Guang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-20       Impact factor: 5.555

3.  Risk Factors for Cervical Lymph Node Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Padmanaban Annaiyappanaidu; Nabil Siraj; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

4.  Supraclavicular Approach of Lobectomy Improves Quality of Life for Patients With Unilateral Papillary Thyroid Microcarcinoma: A Prospective Cohort Study.

Authors:  Shuai Xue; Qiuli Wang; Guang Chen; Peisong Wang; Li Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-04       Impact factor: 5.555

5.  Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.

Authors:  Xiaojun Zhang; Wenkuan Chen; Qigen Fang; Jie Fan; Lu Feng; Lanwei Guo; Shanting Liu; Hong Ge; Wei Du
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-15       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.